On FCS Awareness Day, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced the launch of its new disease awareness campaign, “We’ll Get There Soon,” aimed at providing hope to the community affected by Familial Chylomicronemia Syndrome (FCS). The campaign focuses on raising…
Siemens Healthineers is introducing a new solution that consolidates 25 tasks traditionally performed manually by clinical laboratory staff, reducing manual workflow steps by 75%. This innovation redefines automation in clinical labs. Conventional total laboratory automation relies on tracks to transport…
UnitedHealthcare has announced a major expansion of its Individual & Family Affordable Care Act (ACA) Marketplace plans, now available in 30 states. This includes new coverage in Indiana, Iowa, Nebraska, and Wyoming, along with additional counties in 13 other states.…
ClearNote Health, focused on early cancer detection, has announced findings from a cost-effectiveness analysis of the Avantect Pancreatic Cancer test for managing new-onset diabetes (NOD) patients. This analysis, conducted with the Mayo Clinic and Arizona Centers for Digestive Health, will…
Bristol Myers Squibb (NYSE: BMY) has announced new topline results from the Phase 3 EMERGENT-4 and EMERGENT-5 open-label trials, which assessed the long-term efficacy, safety, and tolerability of COBENFY™ (xanomeline and trospium chloride) in adults with schizophrenia over 52 weeks…
BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and the developer of the Revi® System for urge urinary incontinence (UUI), has announced the publication of a comprehensive meta-analysis in the October issue of Advances in Therapy. Titled “Sacral…
athenahealth, a top provider of network-enabled software and services for healthcare practices across the country, has launched athenaOne for Orthopedics. This comprehensive solution combines EHR, revenue and practice management, and patient engagement features specifically designed for orthopedists. By investing further…
KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology company specializing in innovative large-volume subcutaneous infusion solutions, recently shared data highlighting nursing preference for the KORU FreedomEdge® Infusion System for administering subcutaneous oncology infusions in clinical settings. These findings…
Parse Biosciences, a leader in affordable and scalable single-cell sequencing solutions, has launched Parse GigaLab™, designed to enable single-cell sequencing for billions of cells annually. GigaLab utilizes Parse’s Evercode™ technology, enhanced by an expanded workflow and increased automation, facilitating groundbreaking…
ZOLL®, an Asahi Kasei company specializing in medical devices and software solutions, has announced the results of two significant studies on the economic burden of heart failure resulting from severe heart attacks and the long-term cost-effectiveness of SuperSaturated Oxygen (SSO2)…
